Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
ALXN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 7.84%348.830.0%$6043.00m
ALXNAlexion Pharmaceuticals, Inc. 0.00%182.502.0%$1481.47m
NVAXNovavax, Inc. -3.17%203.2479.8%$838.29m
SNSSSunesis Pharmaceuticals, Inc. -4.84%10.610.7%$741.68m
BNTXBioNTech SE 0.35%281.960.0%$733.79m
NTLAIntellia Therapeutics, Inc. -6.88%137.712.3%$600.33m
BIIBBiogen, Inc. -0.29%325.401.7%$545.25m
AMGNAmgen, Inc. 1.22%247.721.3%$535.64m
VRTXVertex Pharmaceuticals, Inc. 2.29%200.501.9%$451.71m
REGNRegeneron Pharmaceuticals, Inc. -0.09%586.352.7%$444.01m
GILDGilead Sciences, Inc. 0.54%69.021.0%$387.27m
ILMNIllumina, Inc. 1.85%495.513.5%$275.98m
CRSPCRISPR Therapeutics AG -2.00%122.270.6%$200.86m
OCGNOcugen, Inc. -1.98%6.940.0%$163.77m
EXASEXACT Sciences Corp. -0.07%117.9518.1%$129.94m

Company Profile

Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.